MBIA (MBI) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Nov, 2025Executive summary
Consolidated GAAP net loss narrowed to $8 million ($0.17/share) for Q3 2025, a significant improvement from $56 million loss in Q3 2024, mainly due to PREPA exposure resolution and higher recoveries at National.
Adjusted net income (non-GAAP) was $51 million ($1.03/share) for Q3 2025, up from an adjusted net loss of $174,000 in Q3 2024, reflecting improved recoveries and asset sales.
PREPA-related developments, including the sale of $374 million in bankruptcy claims and custodial receipts, reduced exposure and generated gains above prior estimates.
No new financial guarantee policies were written outside of remediation activities.
For the nine months ended September 30, 2025, consolidated GAAP net loss was $126 million ($2.57/share), down from $396 million ($8.37/share) in the same period of 2024.
Financial highlights
Total revenues were $15 million for Q3 2025, down from $29 million in Q3 2024; nine-month revenues were $52 million, down from $396 million year-over-year.
National reported statutory net income of $73 million, up from $19 million year-over-year.
MBIA Insurance Corp reported a statutory net loss of $25 million, compared to net income of $2 million in Q3 2024.
Insurance loss recoverable and loss reserves decreased primarily due to PREPA-related transactions.
50.5 million common shares outstanding as of October 31, 2025.
Outlook and guidance
PREPA exposure remains a priority, but timing and path to resolution are uncertain, with potential for material impact on future loss reserves and recoveries.
No expectation to write new financial guarantee business outside of remediation.
Special dividends and further shareholder returns considered as book runs off and liquidity remains strong.
Management continues to focus on portfolio surveillance, remediation, and maximizing recoveries.
Latest events from MBIA
- Virtual annual meeting to vote on directors, pay, and auditors, with strong governance focus.MBI
Proxy filing23 Mar 2026 - 2025 net losses narrowed, PREPA exposure reduced, and investor call set for February 27, 2026.MBI
Q4 202527 Feb 2026 - Q3 2024 net loss narrowed to $56M, but PREPA risks and negative book value persist.MBI
Q3 202412 Feb 2026 - 2024 net loss narrowed, but adjusted losses rose and PREPA uncertainty persists.MBI
Q4 202412 Feb 2026 - Q2 net loss hit $254M on PREPA charges; book value fell to negative $39.07.MBI
Q2 20242 Feb 2026 - Annual meeting to vote on directors, pay, auditors, and incentive plan; board is majority independent.MBI
Proxy Filing2 Dec 2025 - Net loss narrowed, PREPA claim marketability improved, but litigation uncertainty persists.MBI
Q2 202523 Nov 2025 - Q1 2025 net loss narrows, PREPA risk remains, statutory capital and liquidity strong.MBI
Q1 202520 Nov 2025